Case Western spin-out CardioInsight sells to Medtronic for $93m.

Medtech firm Medtronic has acquired Case Western Reserve University life sciences spin-out CardioInsight for $93m.

CardioInsight, which is developing technology to map electrical disorders in the heart, has previously raised $36.1m, notably a $15m series C in 2013. Its backers include West Capital Advisors, JumpStart, and Draper Triangle Ventures.

Reggie Groves, vice president and general manager of Medtronic’s atrial fibrillation business, said: “This investment aligns with our goal to deliver breakthrough technologies for patients who have atrial fibrillation and other arrhythmias. CardioInsight will broaden and enhance the existing AF Solutions program at Medtronic, and will provide meaningful clinical and economic solutions for patients, hospitals, physicians and payers.”

 

This article is part of Global University Venturing’s free-to-access month. Subscriptions taken out this month will be 25% off.